首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1516032

電子臨床結果評估 (eCOA) 解決方案市場 - 按類型、部署模型、服務類型、最終用途和預測，2024 年 - 2032 年

Electronic Clinical Outcome Assessment (eCOA) Solution Market - By Type, Deployment Model, Service Type, End-use & Forecast, 2024 - 2032

出版日期: 2024年04月01日 | 出版商:

Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於完善的醫療基礎設施和政府推動數位醫療技術的積極舉措，全球電子臨床結果評估 (eCOA) 解決方案市場在 2024 年至 2032 年期間將以 14.3% 的複合年成長率成長。慢性病盛行率的不斷上升是市場成長的主要動力。據世界衛生組織稱，非傳染性疾病 (NCD) 每年奪去 4,100 萬人的生命，佔全球死亡人數的 74%。隨著人口老化和生活方式的改變，糖尿病、心血管疾病、呼吸系統疾病等慢性疾病呈現上升趨勢。

隨著這些疾病的負擔不斷增加，需要更有效的方法來監測患者的結果和治療效果。 eCOA 解決方案透過實現遠端資料收集、即時監控和個人化干預，為慢性病管理提供主動方法。透過促進及時介入和改善患者管理，eCOA 解決方案在應對慢性病盛行率日益上升的挑戰方面發揮著至關重要的作用，從而促進市場成長。

電子臨床結果評估 (eCOA) 解決方案產業根據類型、部署模型、服務類型、最終用途和區域進行分類。

臨床報告結果 (ClinRO) 部分將在 2032 年之前穩定成長，因為 ClinRO 評估提供了有關介入措施對臨床狀態和患者整體健康影響的寶貴資訊。此外，它們的需求更大，因為它們可以直接從患者收集臨床相關資料。透過這種方式，衛生專業人員可以準確評估疾病的嚴重程度、治療的有效性以及患者描述的症狀。此外，ClinRO 評估提供的靈活性，允許問卷適應特定的治療領域，促進了其在各種臨床試驗中的採用。

隨著醫療保健提供者使用 eCOA 解決方案來追蹤患者結果、追蹤疾病進展和最佳化治療策略，醫療保健提供者細分市場的電子臨床結果評估市場將在 2032 年強勁成長。隨著我們轉向基於價值的護理和以患者為中心的醫療保健提供模式，醫療保健提供者擴大使用 eCOA 解決方案來改善患者護理和臨床結果。此外，eCOA資料與電子健康記錄 (EHR) 的整合可實現無縫資料交換和互通性，從而促進醫療保健提供者採用 eCOA 解決方案。

由於完善的醫療基礎設施和政府推動數位醫療技術的積極舉措，歐洲電子臨床結果評估產業將在 2032 年快速成長。英國、德國和法國等國家處於 eCOA 採用的前沿，並且擴大投資於臨床試驗和研究。歐洲嚴格的監管環境確保了資料保護和資料安全的高標準，增強了利害關係人的信心，並促進了 eCOA 解決方案的廣泛採用。此外，學術界、工業界和監管機構之間的合作將推動創新並加速先進 eCOA 技術的開發和採用，從而推動市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 從紙本程式逐漸轉向電子資料收集
  - eCOA 模式不斷進步
  - 擴大採用基於雲端的服務
  - 政府對臨床試驗的有利支持與資助
- 產業陷阱與挑戰
  - 操作 eCOA 的熟練專業人員嚴重缺乏
  - 對資料安全和隱私的擔憂
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
臨床醫師報告的結果 (ClinRO)
患者報告的結果 (PRO)
觀察員報告結果 (ObsRO)
績效結果 (PerfO)

第 6 章：市場估計與預測：按部署模型，2021 - 2032 年

主要趨勢
獲得許可的企業（本地）解決方案
基於雲端的解決方案
網頁寄存（按需）解決方案

第 7 章：市場估計與預測：按服務類型，2021 - 2032 年

主要趨勢
自帶裝置模型 (BYOD)
已配置的設備型號

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物製藥公司
醫療保健機構
- 醫院
- 診所
合約研究組織 (CRO)
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 10 章：公司簡介

AssisTek
Climedo Health GmbH
Clinical ink
CRF Health
EvidentIQ
ICON plc
IQVIA
Integra IT S.A.S
Kayentis
Medidata
Oracle Corporation
Raylytic GmbH
Signant Health
Veeva Systems

簡介目錄

Product Code: 8777

Global Electronic Clinical Outcome Assessment (eCOA) solutions market will grow at 14.3% CAGR during 2024-2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. The increasing prevalence of chronic diseases is acting as a major driver for market growth. According to the WHO, non-communicable diseases (NCDs) claim 41 million lives each year, accounting for 74 percent of global deaths. As the population ages and lifestyles change, chronic diseases such as diabetes, cardiovascular diseases, and respiratory diseases are on the rise.

As the burden of these diseases continues to increase, more effective methods are needed to monitor patient outcomes and treatment efficacy. eCOA solutions provide a proactive approach to chronic disease management by enabling remote data collection, real-time monitoring, and personalized interventions. By facilitating timely intervention and improving patient management, eCOA solutions play a crucial role in addressing the challenges of the increasing prevalence of chronic diseases, thereby inducing market growth.

Electronic Clinical Outcome Assessment (eCOA) Solutions industry is classified based on type, deployment model, service type, end use, and region.

The Clinical-Reported Outcomes (ClinRO) segment will grow steadily through 2032, as ClinRO assessments provide valuable information about the impact of interventions on clinical status and the general well-being of patients. In addition, they are more in demand because they can collect clinically relevant data directly from patients. In this way, health professionals can accurately assess the severity of the disease, the effectiveness of the treatment, and the symptoms described by the patient. In addition, the flexibility offered by ClinRO assessments, allowing questionnaires adapted to specific treatment areas, promotes their adoption in various clinical trials.

The electronic clinical outcome assessment market from the healthcare provider segment will grow strongly through 2032 as healthcare providers use eCOA solutions to track patient outcomes, track disease progression, and optimize treatment strategies. As we move towards value-based care and patient-centered healthcare delivery models, healthcare providers are increasingly using eCOA solutions to improve patient care and clinical outcomes. In addition, the integration of eCOA data with electronic health records (EHR) enables seamless data exchange and interoperability, which promotes the adoption of eCOA solutions among healthcare providers.

Europe Electronic Clinical Outcome Assessment industry will grow rapidly through 2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. Countries such as the UK, Germany, and France are at the forefront of eCOA adoption and are increasingly investing in clinical trials and research. Europe's strict regulatory environment ensures high standards of data protection and data security, increases stakeholder confidence, and promotes the widespread adoption of eCOA solutions. In addition, collaboration between academia, industry, and regulatory agencies will drive innovation and accelerate the development and adoption of advanced eCOA technologies that will drive market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Gradual shift towards electronic data capturing from paper-based procedures
  - 3.2.1.2 Growing advancements in eCOA modalities
  - 3.2.1.3 Growing adoption of cloud-based services
  - 3.2.1.4 Favorable government support and funding for clinical trials
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High dearth of skilled professionals to operate eCOA
  - 3.2.2.2 Concern about data security and privacy
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Clinician-reported outcome (ClinRO)
5.3 Patient-reported outcome (PRO)
5.4 Observer-reported outcome (ObsRO)
5.5 Performance outcome (PerfO)

Chapter 6 Market Estimates and Forecast, By Deployment Model, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Licensed enterprise (on-premises) solutions
6.3 Cloud-based solutions
6.4 Web-hosted (on-demand) solutions

Chapter 7 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Bring-your own device model (BYOD)
7.3 Provisioned device model

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biopharmaceutical companies
8.3 Healthcare providers
- 8.3.1 Hospitals
- 8.3.2 Clinics
8.4 Contract research organizations (CROs)
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa